Alkoxy cyanoacrylate-based nanoparticles with stealth and brain-targeting properties

Area of Science:

• Nanotechnology
• Drug Delivery
• Biomedical Engineering

Background:

• Stealth nanoparticles improve drug circulation and bioavailability by reducing phagocytosis.
• Brain-targeting nanoparticles are crucial for treating central nervous system diseases like glioma.
• Current nanoparticle formulations face challenges in crossing the blood-brain barrier and evading immune clearance.

Purpose of the Study:

• To synthesize and evaluate novel alkoxy cyanoacrylate (CA)-based nanoparticles with stealth and brain-targeting properties.
• To investigate the potential of these nanoparticles for delivering anti-sense oligonucleotide (ASON) of transforming growth factor beta 2 to brain tumors.
• To compare the efficacy of the newly designed nanoparticles against traditional ones in terms of phagocytosis, cellular uptake, and brain targeting.

Main Methods:

• Synthesis of alkoxy CA-based nanoparticles (NP2 and NP3) using modified monomers for stealth properties.
• Coating nanoparticles with polysorbate-80 to enhance brain targeting capabilities.
• Loading nanoparticles with anti-sense oligonucleotide (ASON) targeting transforming growth factor beta 2.
• In vitro evaluation of nanoparticle phagocytosis by macrophages (RAW264.7) and cellular uptake by cancer cells.
• Assessment of brain targeting and anti-cancer effects of the optimized nanoparticle formulation (ASON-NP3).

Main Results:

• Successfully synthesized stealth and brain-targeting alkoxy CA-based nanoparticles (NP2 and NP3) loaded with ASON.
• ASON-NP3 demonstrated reduced phagocytosis by mononuclear macrophages compared to traditional ASON-NP1.
• ASON-NP3 exhibited increased cellular uptake by cancer cells.
• Significant brain targeting and anti-cancer effects were observed with ASON-NP3.
• The modified CA-based nanoparticles showed improved stealth properties and enhanced targeting efficacy.

Conclusions:

• Alkoxy cyanoacrylate-based nanoparticles offer a promising strategy for developing stealth nanoparticle cores.
• The developed nanoparticles exhibit effective brain targeting and enhanced anti-cancer activity.
• This novel nanoparticle vehicle has the potential for extended blood circulation and targeted drug delivery to the brain for treating diseases like glioma.